Year |
Citation |
Score |
2007 |
Laakso MM, Lee FH, Haggarty B, Agrawal C, Nolan KM, Biscone M, Romano J, Jordan AP, Leslie GJ, Meissner EG, Su L, Hoxie JA, Doms RW. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies. Plos Pathogens. 3: e117. PMID 17722977 DOI: 10.1371/Journal.Ppat.0030117 |
0.567 |
|
2006 |
Biscone MJ, Miamidian JL, Muchiri JM, Baik SS, Lee FH, Doms RW, Reeves JD. Functional impact of HIV coreceptor-binding site mutations. Virology. 351: 226-36. PMID 16631222 DOI: 10.1016/J.Virol.2006.03.017 |
0.583 |
|
2006 |
Haskell CA, Horuk R, Liang M, Rosser M, Dunning L, Islam I, Kremer L, Gutiérrez J, Marquez G, Martinez-A C, Biscone MJ, Doms RW, Ribeiro S. Identification and characterization of a potent, selective nonpeptide agonist of the CC chemokine receptor CCR8. Molecular Pharmacology. 69: 309-16. PMID 16221874 DOI: 10.1124/Mol.105.014779 |
0.531 |
|
2004 |
Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate. Journal of Virology. 78: 13430-9. PMID 15564453 DOI: 10.1128/Jvi.78.24.13430-13439.2004 |
0.385 |
|
2004 |
Reeves JD, Miamidian JL, Biscone MJ, Lee FH, Ahmad N, Pierson TC, Doms RW. Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity. Journal of Virology. 78: 5476-85. PMID 15113926 DOI: 10.1128/Jvi.78.10.5476-5485.2004 |
0.589 |
|
2002 |
Biscone MJ, Pierson TC, Doms RW. Opportunities and challenges in targeting HIV entry. Current Opinion in Pharmacology. 2: 529-33. PMID 12324254 DOI: 10.1016/S1471-4892(02)00200-X |
0.54 |
|
Show low-probability matches. |